Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity.

Haiaty S, Rashidi M-R, Akbarzadeh M, Bazmany A, Mostafazadeh M, Nikanfar S, Shabkhizan R, Rezaeian R, Rahbarghazi R, Nouri M. Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity. Bioimpacts. 2023;13(5):405-413.